Integrated Network Pharmacology and Experimental Verification to Explore the Molecular Mechanism of Hedysarum Multijugum Maxim–Curcumae Rhizoma Herb Pair for Treating Non-Small Cell Lung Cancer

Integrated Network Pharmacology and Experimental Verification to Explore the Molecular Mechanism of Hedysarum Multijugum Maxim–Curcumae Rhizoma Herb Pair for Treating Non-Small Cell Lung Cancer

BackgroundHedysarum Multijugum Maxim–Curcumae Rhizoma (HMMCR), a well-known herb pair in traditional Chinese medicine (TCM), has been widely used for the treatment of various cancers. However, the active components of HMMCR and the underlying mechanism of HMMCR for non-small-cell lung carcinoma (NSC...

Full description

Bibliographic Details
Main Authors: Shaopu Hu, Mengxue Ge, Shuixiu Zhang, Min Jiang, Kaiwen Hu, Lei Gao
Format: Article
Language:English
Published: Frontiers Media S.A. 2022-03-01
Series:Frontiers in Oncology
Subjects:
Hedysarum Multijugum Maxim
Curcumae Rhizoma
network pharmacology
PI3K/Akt signaling pathway
NSCLC
Online Access:https://www.frontiersin.org/articles/10.3389/fonc.2022.854596/full

Internet

https://www.frontiersin.org/articles/10.3389/fonc.2022.854596/full

Similar Items